RENEXXION LLC has a total of 11 patent applications. Its first patent ever was published in 2005. It filed its patents most often in Australia, Norway and Taiwan. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are CTI BIOPHARMA CORP, INVENTISBIO SHANGHAI LTD and KASINA LAILA INNOVA PHARMACEUTICALS PRIVATE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Norway | 2 | |
#3 | Taiwan | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Druzgala Pascal Jean | 6 |
#2 | Tien Jien Heh | 5 |
#3 | Milner Peter | 5 |
#4 | Druzgala Pascal | 3 |
#5 | Palme Monica | 3 |
#6 | Rubens Courtney | 3 |
#7 | Becker Cyrus | 3 |
#8 | Irwin Ian | 3 |
#9 | Pang Ponny | 2 |
#10 | Yeh J B | 2 |
Publication | Filing date | Title |
---|---|---|
TW202024081A | Methods of producing naronapride trihydrate | |
US10570127B1 | Material and methods for the treatment of gastro-intestinal disorders | |
AU2006284601A1 | Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders |